Clinical trial
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With…
NCT00095121 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00095121 |
|---|---|
| Title | Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B |
| Official title | A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to Less Than 18) With Chronic Hepatitis B |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Placebo (PLB), Adefovir Dipivoxil (ADV), Lamivudine |
| Enrollment | 173 |
| Start date | Jun 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Apr 1, 2010 |
| First posted | Nov 1, 2004 |
| Last update posted | May 22, 2012 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: